| The effect of cardiac resynchronization on morbidity and mortality in heart failure JGF Cleland, JC Daubert, E Erdmann, N Freemantle, D Gras, ... New England Journal of Medicine 352 (15), 1539-1549, 2005 | 6446 | 2005 |
| Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension M Calvert, J Blazeby, DG Altman, DA Revicki, D Moher, MD Brundage, ... Jama 309 (8), 814-822, 2013 | 1169 | 2013 |
| Composite outcomes in randomized trials: greater precision but with greater uncertainty? N Freemantle, M Calvert, J Wood, J Eastaugh, C Griffin Jama 289 (19), 2554-2559, 2003 | 770 | 2003 |
| Symptoms, complications and management of long COVID: a review OL Aiyegbusi, SE Hughes, G Turner, SC Rivera, C McMullan, ... Journal of the Royal Society of Medicine 114 (9), 428-442, 2021 | 637 | 2021 |
| Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension X Liu, SC Rivera, D Moher, MJ Calvert, AK Denniston, H Ashrafian, ... The Lancet Digital Health 2 (10), e537-e548, 2020 | 628 | 2020 |
| Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension M Calvert, D Kyte, R Mercieca-Bebber, A Slade, AW Chan, MT King, ... Jama 319 (5), 483-494, 2018 | 617 | 2018 |
| Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension SC Rivera, X Liu, AW Chan, AK Denniston, MJ Calvert, H Ashrafian, ... The Lancet Digital Health 2 (10), e549-e560, 2020 | 529 | 2020 |
| Cardiac resynchronization therapy for heart failure WT Abraham, DL Hayes Circulation 108 (21), 2596-2603, 2003 | 506 | 2003 |
| Symptoms and risk factors for long COVID in non-hospitalized adults A Subramanian, K Nirantharakumar, S Hughes, P Myles, T Williams, ... Nature medicine 28 (8), 1706-1714, 2022 | 387 | 2022 |
| The importance of patient-reported outcomes in clinical trials and strategies for future optimization R Mercieca-Bebber, MT King, MJ Calvert, MR Stockler, M Friedlander Patient related outcome measures, 353-367, 2018 | 368 | 2018 |
| The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials SD Anker, S Agewall, M Borggrefe, M Calvert, J Jaime Caro, MR Cowie, ... European heart journal 35 (30), 2001-2009, 2014 | 363 | 2014 |
| The impact of chronic heart failure on health‐related quality of life data acquired in the baseline phase of the CARE‐HF study MJ Calvert, N Freemantle, JGF Cleland European journal of heart failure 7 (2), 243-251, 2005 | 288 | 2005 |
| Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial) TD Pinkney, M Calvert, DC Bartlett, A Gheorghe, V Redman, G Dowswell, ... Bmj 347, 2013 | 271 | 2013 |
| An introduction to patient-reported outcome measures (PROMs) in physiotherapy DG Kyte, M Calvert, PJ Van der Wees, R Ten Hove, S Tolan, JC Hill Physiotherapy 101 (2), 119-125, 2015 | 256 | 2015 |
| Maximising the impact of patient reported outcome assessment for patients and society M Calvert, D Kyte, G Price, JM Valderas, NH Hjollund Bmj 364, 2019 | 248 | 2019 |
| Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High … P Kirchhof, BF Blank, M Calvert, AJ Camm, G Chlouverakis, HC Diener, ... American heart journal 190, 12-18, 2017 | 227 | 2017 |
| Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study M Calvert, A Shankar, RJ McManus, H Lester, N Freemantle Bmj 338, 2009 | 224 | 2009 |
| The heart failure revascularisation trial (HEART) JGF Cleland, M Calvert, N Freemantle, Y Arrow, SG Ball, RS Bonser, ... European journal of heart failure 13 (2), 227-233, 2011 | 223 | 2011 |
| Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards M Brundage, J Blazeby, D Revicki, B Bass, H De Vet, H Duffy, F Efficace, ... Quality of Life Research 22, 1161-1175, 2013 | 217 | 2013 |
| The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator G Yao, N Freemantle, MJ Calvert, S Bryan, JC Daubert, JGF Cleland European heart journal 28 (1), 42-51, 2007 | 215 | 2007 |
